EyePoint Pharmaceuticals, Inc. ( EYPT) - Key Metrics
EYPT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | -$0.81 | -$0.78 | -$0.80 |
| 2025Q3 | $0.01 | -$0.85 | -$0.85 | -$0.86 |
| 2025Q2 | $0.08 | -$0.85 | -$0.90 | -$0.91 |
| 2025Q1 | $0.35 | -$0.65 | -$0.76 | -$0.77 |
EYPT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -5.61 |
| 2025Q3 | ? | -4.18 |
| 2025Q2 | ? | -2.77 |
| 2025Q1 | ? | -2.09 |
EYPT
Price: $12.08
52 week price:
Earnings Per Share: -3.51 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 166382
Market Capitalization: 987.7 million